PFIZER ZAMIFENACIN TRIALS INCLUDE COST-EFFECTIVENESS STUDY OF SICK DAYS, FIRM TELLS SHAREHOLDERS: IRRITABLE BOWEL SYNDROME TREATMENT MOVES INTO PHASE III

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".